| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,110,000 |
| Market
Cap: |
5.48(M) |
| Last
Volume: |
4,769,812 |
Avg
Vol: |
4,756,624 |
| 52
Week Range: |
$0.2598 - $0.2598 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Plus Therapeutics is a clinical-stage pharmaceutical company focused on the development, manufacture and commercialization of treatments for patients battling cancer and other life-threatening diseases. The clinical stage drugs in Co.'s pipeline are: Rhenium NanoLiposomes, a radiotherapy for patients with recurrent glioblastoma; DocePLUS™, a chemotherapy for patients with tumors that has been evaluated in a completed U.S. single-center Phase 1 clinical trial; and DoxoPLUS™, a generic chemotherapy that has been evaluated in a completed, bioequivalence clinical trial in the U.S., Canada, and Ukraine versus Janssen's CAELYX® in patients with ovarian cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
48,285 |
50,285 |
100,872 |
153,373 |
| Total Buy Value |
$98,501 |
$102,221 |
$185,764 |
$224,195 |
| Total People Bought |
6 |
6 |
6 |
6 |
| Total Buy Transactions |
6 |
8 |
17 |
22 |
| Total Shares Sold |
0 |
2,068 |
2,068 |
3,568 |
| Total Sell Value |
$0 |
$4,053 |
$4,053 |
$4,525 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
1 |
1 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rickey David |
Director |
– • – |
2014-06-05 |
4 |
B |
$2.32 |
$70,071 |
I/I |
30,000 |
135,059 |
2.1 |
- |
|
| Lyons Gary A |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,409 |
24,409 |
|
- |
|
| Dean Lloyd H |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,409 |
13,959 |
|
- |
|
| Thompson Tommy G |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,501 |
16,051 |
|
- |
|
| Hawkins Richard J |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,191 |
15,741 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,867 |
13,417 |
|
- |
|
| Hawran Paul W |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,862 |
16,412 |
|
- |
|
| Rickey David |
Director |
– • – |
2014-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,269 |
15,819 |
|
- |
|
| Hedrick Marc H |
President & CEO |
• • – |
2014-03-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
3,600 |
|
- |
|
| Lim Kian Thiam |
10% Owner |
– – • |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,000,000 |
|
- |
|
| Calhoun Christopher J |
Chief Executive Officer |
• • – |
2014-01-10 |
4 |
AS |
$2.81 |
$442,814 |
D/D |
(29,145) |
118,125 |
|
- |
|
| Hawkins Richard J |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Holmes E Carmack |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Rickey David |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Hawran Paul W |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Dean Lloyd H |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Thompson Tommy G |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,550 |
10,550 |
|
- |
|
| Rickey David |
Director |
– • – |
2013-12-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
29,519 |
0 |
|
- |
|
| Lyons Gary A |
Director |
– • – |
2013-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
|
- |
|
| Rickey David |
Director |
– • – |
2013-09-12 |
4 |
B |
$2.52 |
$18,098 |
I/I |
7,100 |
200,076 |
2.1 |
- |
|
| Rickey David |
Director |
– • – |
2013-09-11 |
4 |
B |
$2.57 |
$8,990 |
I/I |
3,500 |
115,059 |
2.1 |
- |
|
| Rickey David |
Director |
– • – |
2013-09-11 |
4 |
B |
$2.54 |
$2,540 |
I/I |
1,000 |
192,976 |
2.1 |
- |
|
| Rickey David |
Director |
– • – |
2013-09-10 |
4 |
B |
$2.62 |
$2,620 |
I/I |
1,000 |
191,976 |
2.1 |
- |
|
| Rickey David |
Director |
– • – |
2013-09-09 |
4 |
B |
$2.37 |
$4,740 |
I/I |
2,000 |
190,976 |
2.1 |
- |
|
| Rickey David |
Director |
– • – |
2013-09-06 |
4 |
B |
$2.27 |
$6,810 |
I/I |
3,000 |
188,976 |
2.1 |
- |
|
340 Records found
|
|
Page 5 of 14 |
|
|
